AIROS Medical Announces Five-Year Warranty on Lymphedema Pneumatic Compression Devices
The AIROS 6P and AIROS 8P sequential compression devices now have a five-year warranty. The previous warranty for these devices was three years. All devices sold after
"Our team at AIROS Medical incorporates a vigorous quality standard with regards to all aspects of our business, including our device line's long-term reliability," said
AIROS Medical's product line also includes garments that treat lymphedema present in the upper extremities, lower extremities, and truncal region. Patients battling chronic venous insufficiency (CVI) can also utilize prescription-only devices and garments manufactured by AIROS. Visit www.airosmedical.com to learn more.
About AIROS Medical, Inc.
AIROS Medical, Inc. is a medical technology manufacturer and designer specializing in compression therapy. The company's team of engineers, regulatory experts, and clinical partners create medical devices that improve quality of life for patients battling lymphatic and venous disorders. The company's product line includes various pneumatic compression devices and associated compression garments that treat pain and swelling in the upper extremities, lower extremities, pelvic area, abdomen, and chest. AIROS Medical was founded in 2016 and is headquartered in
Contact:
Marketing Manager
+12155892656
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/airos-medical-announces-five-year-warranty-on-lymphedema-pneumatic-compression-devices-302661264.html
SOURCE AIROS Medical
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PPL to Pay Quarterly Stock Dividend Oct. 1, 2026
- WhatsLove AI: Best AI Girlfriend for Video Roleplay in 2026
- LightInTheBox to Report Second Quarter 2026 Financial Results on Wednesday, August 26, 2026
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share